ABVC BioPharma shareholders approve all four proposals including related-party land deal

ABVC BIOPHARMA, INC.

11 directors re-elected with ~5.9M votes for each; 18,525 withheld per director.
Simon & Edward, LLP ratified as auditor for FY2025 with 5,903,606 votes for.
Land purchase from director Shuling Jiang approved (5,832,130 for); may exceed 20% of outstanding shares.
Equity incentive plan increased to 15% of outstanding shares with annual auto-increase approved (5,691,168 for).
Quorum of 5,917,309 shares (35.27% voting power) present for annual meeting.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.